BTIS
SCMP

BB&T Investment Services’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

BB&T Investment Services’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$30K Hold
1,659
– – 0.01% 689
2017
Q3 		$19K Buy
1,659
+123
+8% +$1.38K ﹤0.01% 742
2017
Q2 		$16K Buy
1,536
+574
+60% +$5.85K ﹤0.01% 707
2017
Q1 		$11K Buy
962
+845
+722% +$9.81K ﹤0.01% 712
2016
Q4 		$2K Buy
+117
New +$1.63K ﹤0.01% 722

Other funds holding SCMP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

BB&T Investment Services's SCMP Position: Q4 2017 in Review

BB&T Investment Services held its Sucampo Pharmaceuticals, Inc. (SCMP) position steady in Q4 2017 at 1,659 shares worth $30K. The position accounts for 0.01% of the portfolio, ranked #689.

BB&T Investment Services first reported a position in SCMP in Q4 2016 and has held it in 5 quarters since. 188 funds tracked by Wall St. Rank hold SCMP as of Q4 2017.

  • BB&T Investment Services held 1,659 shares of Sucampo Pharmaceuticals, Inc. worth $30K as of Q4 2017.
  • BB&T Investment Services left its Sucampo Pharmaceuticals, Inc. share count unchanged in Q4 2017.
  • Sucampo Pharmaceuticals, Inc. made up 0.01% of BB&T Investment Services's portfolio in Q4 2017, its #689 holding.
  • BB&T Investment Services first reported a position in Sucampo Pharmaceuticals, Inc. in Q4 2016 and has held it in 5 quarters since.
  • 188 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q4 2017.

Based on BB&T Investment Services's 13F filing for Q4 2017, filed 15 Feb 2018.